Explore our primary industrial portfolio designed for healthcare manufacturers, nutritional compounding facilities, and pharmaceutical labs globally.
Ursodeoxycholic Acid (UDCA), a naturally occurring secondary bile acid, has evolved into a cornerstone therapeutic agent for hepatology and gastroenterology. Originally discovered in bear bile, modern biotechnology and pharmaceutical chemistry allow manufacturers to produce UDCA through chemical synthesis and enzymatic conversion from primary bile acids, eliminating dependency on animal products. This shift ensures consistent quality, strict impurity control, and scaling capabilities that comply with international standards.
UDCA acts as a hydrophilic bile acid, displacing toxic hydrophobic bile acids from the hepatic pool. This action stabilizes hepatocyte membranes and reduces micro-inflammation, slowing the progression of hepatic fibrosis in PBC patients.
For patients with cholesterol gallstones who are ineligible for surgery, oral UDCA decreases biliary cholesterol saturation. This allows cholesterol to gradually disperse from the stones into the bile phase, facilitating dissolution.
Recent research highlights UDCA's role in modulating the Farnesoid X Receptor (FXR) and cytoprotective properties. Emerging clinical trials explore its potential in neurodegenerative conditions, metabolic diseases, and viral pathway inhibition.
How localization, chemical supply chains, and technology drive high-yield, high-purity production for international buyers.
China is home to the world's most integrated bile acid collection and chemical processing clusters. Access to base components like cholic acid and deoxycholic acid enables a uninterrupted raw material pipeline, safeguarding global buyers against supply shocks.
Advanced manufacturers like Chengdu Chenlv Herb incorporate biocatalytic pathways. Multi-enzyme cascade reaction technology replaces heavy metal catalysts, producing clean API profiles with low lithocholic acid (LCA) impurities.
With massive investments in automation, factories are designed in strict accordance with WHO GMP, FDA, and EU GMP requirements. Cleanrooms, automated crystallization loops, and continuous processing plants minimize contamination risks.
We have integrated research and development, manufacturing, and sales together to deliver optimized natural raw materials and active pharmaceutical ingredients.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. (referred to as "Chenlv Herb") operates as a high-tech enterprise specializing in the research, development, production, and sales of botanical extracts and natural pharmaceutical ingredients. We are dedicated to providing high-purity, active, and premium-quality raw materials for pharmaceuticals, health supplements, functional food, animal nutrition, and cosmetics.
By implementing advanced separation, purification, and enzymatic synthesis systems, Chenlv Herb maintains trace impurity profiles in all APIs, including UDCA and similar bile acid derivatives. Our R&D team continuously innovates to meet the regulatory requirements of global drug master files (DMF) and international pharmacopoeias.
Read More About Us
We optimize our processes to deliver dependable raw materials that exceed regulatory expectations.
Continuous R&D yields customized ingredient solutions, molecular modification, and enhanced bioavailability techniques.
Automated manufacturing lines ensure high yields, rapid turnaround times, and stable batch-to-batch consistency.
Green chemistry principles guide our operations, utilizing eco-conscious sourcing and minimal-waste manufacturing pathways.
From initial laboratory testing to large-scale supply chain logistics, we support you through every stage of development.
Strict QA/QC protocols check for heavy metals, residual solvents, pesticides, and microbial counts using HPLC and GC-MS.
With decades of experience, our technical team understands regulatory documentation, DMF filing, and custom synthesis.
Explore our catalog of high-demand botanical and synthetic ingredients used by leading brands worldwide.
Aligning natural biochemical properties with strict end-user sector specifications.
Driven by the concept of "homology of medicine and food", plant extracts are safe, green, and natural active ingredients for high-demand nutraceutical formulas.
Providing essential active ingredients, such as purified UDCA, to serve as active components that meet international pharmacopeial limits and clinical protocols.
Highly sought after for anti-aging, moisturizing, and skin-barrier enhancement formulations where natural active ingredients improve safety and efficacy profiles.
Leveraging bile acids and plant extracts to enhance digestion, liver function, and immunity in livestock and aquaculture systems, replacing antibiotics.
Our standardized workflow from initial chemical request to batch delivery.
All materials comply with critical global standards: ISO9001, ISO22000, HALAL, KOSHER, and FDA.
Stay updated with our research breakthroughs and event schedule across international tradeshows.
Market Trends
With changing supply-demand dynamics at the end of the production season, price fluctuations are drawing significant strategic focus from key industry stakeholders.
Read More
Exhibitions
Join our technical team at CPHI China 2025 to discuss next-generation biotransformation models, custom syntheses, and supply-chain risk mitigation schemes.
Read More
Corporate Event
We invite global buyers to the China Import and Export Fair Exhibition Hall in Guangzhou to explore our high-purity API offerings and custom synthesis capabilities.
Read MoreSourcing active pharmaceutical ingredients requires close alignment with international regulatory frameworks. To support pharmaceutical manufacturers and formulation brands, our operations focus on the following key operational sectors:
The control of lithocholic acid (LCA)—a hepatotoxic compound—is critical. Our production limits LCA impurities to well below standard pharmacopoeia limits, verified by precise HPLC assays, ensuring patient safety and regulatory approval.
To streamline your drug registration processes, we provide comprehensive Drug Master File (DMF) documentation. This support helps you navigate regulatory requests from agencies such as the US FDA, EMA, and PMDA.
We offer customized physical properties, including particle size micronization. This control helps target specific dissolution profiles and tablet compaction properties for finished formulations.
Quick answers to key technical, supply chain, and regulatory questions from international procurement managers.
Keep up with chemical price lists, supply chain reports, and new botanical innovations. For product pricing inquiries, please submit your target specifications and we will get back to you within 24 hours.
Explore our specialized extracts, certified derivatives, and customized pricing catalogs.
Chenlv Herb
